Search This Blog

Friday, August 7, 2026

Treace Medical Concepts raises 2026 outlook, expects ~50% lower cash usage

 

Treace Medical Concepts raises 2026 outlook, guides revenue to $204–$212 million, adjusted EBITDA loss to $3–$5 million, expects ~50% lower cash usage

  • Company targets reducing full-year 2026 cash usage by about 50% through restructuring actions and operational efficiencies.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)